• Psychometric Evaluation of the Diary for Irritable Bowel Syndrome Symptoms-Constipation in a Prospective Observational Study

    May 1, 2024, 00:00 AM

  • Acceptability of Using Real-World Data to Estimate Relative Treatment Effects in Health Technology Assessments: Barriers and Future Steps [Editor's Choice]

    May 1, 2024, 00:00 AM

  • Economic Evaluations of Establishing Opioid Overdose Prevention Centers in 12 North American Cities: A Systematic Review

    May 1, 2024, 00:00 AM

  • Valuation of EQ-5D-5L in the Kingdom of Saudi Arabia: A National Representative Study [Editor's Choice]

    May 1, 2024, 00:00 AM

  • Public Acceptance of Measures to Control Infectious Diseases Under Different Scenarios of Severity and Transmissibility [Editor's Choice]

    May 1, 2024, 00:00 AM

  • Mapping Health Technology Assessment Agency Approaches for Biosimilar Value Assessment: An ISPOR Special Interest Group Report [Editor's Choice]

    May 1, 2024, 00:00 AM

  • Toward the Implementation of a Value Framework for Diagnostic Technologies: Operationalization, Piloting, and Validation in Latin America

    May 1, 2024, 00:00 AM

  • EQ-5D-5L Population Norms and Quality-Adjusted Life Expectancy by Sociodemographic Characteristics and Modifiable Risk Factors for Adults in Queensland, Australia

    May 1, 2024, 00:00 AM

  • Development and Valuation of a Preference-Weighted Measure in Age-Related Macular Degeneration From the Vision Impairment in Low Luminance Questionnaire: A MACUSTAR Report

    May 1, 2024, 00:00 AM

  • Meaningful Symptomatic Change in Patients With Myelofibrosis From the SIMPLIFY Studies

    May 1, 2024, 00:00 AM

  • Table of Contents

    May 1, 2024, 00:00 AM

  • Editorial Board

    Apr 1, 2024, 08:56 AM

  • A Comparison of Items and Constructs of Standardized Health-Related Quality of Life and Mental Well-Being Measures

    Apr 1, 2024, 00:00 AM

  • Evaluating Policies of Expanding Versus Restricting First-Line Treatment Choices: A Cost-Effectiveness Analysis Framework [Editor's Choice]

    Apr 1, 2024, 00:00 AM

  • Evaluating Recall Periods for Patient-Reported Outcome Measures: A Systematic Review of Quantitative Methods

    Apr 1, 2024, 00:00 AM

  • Validation of China Health-Related Outcomes Measures-Cardiovascular Disease

    Apr 1, 2024, 00:00 AM

  • The Determination of Diabetes Utilities, Costs, and Effects Model: A Cost-Utility Tool Using Patient-Level Microsimulation to Evaluate Sensor-Based Glucose Monitoring Systems in Type 1 and Type 2 Diabetes: Comparative Validation

    Apr 1, 2024, 00:00 AM

  • Economic Evaluation of an Enhanced Post-Discharge Home-Based Care Program for Stroke Survivors

    Apr 1, 2024, 00:00 AM

  • The PICOTS-ComTeC Framework for Defining Digital Health Interventions: An ISPOR Special Interest Group Report

    Apr 1, 2024, 00:00 AM

  • Cost and Utility Estimates per Modified Rankin Scale Score up to 2 Years Post Stroke: Data to Inform Economic Evaluations From a Societal Perspective

    Apr 1, 2024, 00:00 AM

  • The Cost of Atrial Fibrillation: A Systematic Review

    Apr 1, 2024, 00:00 AM

  • Table of Contents

    Apr 1, 2024, 00:00 AM

  • Cost of Illness of Head and Neck Cancer in Sweden

    Apr 1, 2024, 00:00 AM

  • Exploring the Comparability Between EQ-5D and the EQ Health and Wellbeing in the General Australian Population

    Apr 1, 2024, 00:00 AM

  • Benefit-Harm Analysis for Informed Decision Making on Participating in Colorectal Cancer Screening: A Modeling Study

    Apr 1, 2024, 00:00 AM

  • Discrete Event Simulation to Incorporate Infusion Wait-Time When Assessing Cost-Effectiveness of a Chimeric-Antigen Receptor T Cell Therapy

    Apr 1, 2024, 00:00 AM

  • A Review of Meaningful Change Thresholds for EORTC QLQ-C30 and FACT-G Within Oncology [Editor's Choice]

    Apr 1, 2024, 00:00 AM

  • Estimating a Minimal Important Difference for the EQ-5D-5L Utility Index in Dialysis Patients [Editor's Choice]

    Apr 1, 2024, 00:00 AM

  • Partial Orphan Cancer Drugs: US Food and Drug Administration Approval, Clinical Benefit, Trials, Epidemiology, Price, Beneficiaries, and Spending [Editor's Choice]

    Apr 1, 2024, 00:00 AM

  • Opportunities and Challenges for Decentralized Clinical Trial Approaches: European Health Technology Assessment Perspective

    Mar 1, 2024, 00:00 AM

  • Scoring the Value Assessment Framework for China: A Factorial Survey

    Mar 1, 2024, 00:00 AM

  • Financial Characteristics of Outcomes-Based Agreements: What Do Canadian Public Payers and Pharmaceutical Manufacturers Prefer?

    Mar 1, 2024, 00:00 AM

  • Identifying the Optimum Strategy for Identifying Adults and Children With Celiac Disease: A Cost-Effectiveness and Value of Information Analysis

    Mar 1, 2024, 00:00 AM

  • Are Manufacturing Patents to Blame for Biosimilar Market Launch Delays?

    Mar 1, 2024, 00:00 AM

  • Work Productivity Among Younger Breast Cancer Survivors: The Impact of Behavioral Interventions for Depression

    Mar 1, 2024, 00:00 AM

  • Table of Contents

    Mar 1, 2024, 00:00 AM

  • Quantifying the Value of Reduced Health Disparities: Low-Dose Computed Tomography Lung Cancer Screening of High-Risk Individuals Within the United States

    Mar 1, 2024, 00:00 AM

  • Unanchored Population-Adjusted Indirect Comparison Methods for Time-to-Event Outcomes Using Inverse Odds Weighting, Regression Adjustment, and Doubly Robust Methods With Either Individual Patient or Aggregate Data [Editor's Choice]

    Mar 1, 2024, 00:00 AM

  • Patient Welfare Implications of Indication-Specific Value-Based Pricing of Multi-Indication Drugs [Editor's Choice]

    Mar 1, 2024, 00:00 AM

  • Perils of Randomized Controlled Trial Survival Extrapolation Assuming Treatment Effect Waning: Why the Distinction Between Marginal and Conditional Estimates Matters [Editor's Choice]

    Mar 1, 2024, 00:00 AM

  • Drug Pricing, Patient Welfare, and Cost-Effectiveness Analysis

    Mar 1, 2024, 00:00 AM

  • Logical Inconsistencies in the Health Years in Total and Equal Value of Life-Years Gained [Editor's Choice]

    Mar 1, 2024, 00:00 AM

  • Using the Online Elicitation of Personal Utility Functions Approach to Derive a Patient-Based 5-Level Version of EQ-5D Value Set: A Study in 122 Patients With Rheumatic Diseases From Germany

    Mar 1, 2024, 00:00 AM

  • Modeling Thyroid Cancer Epidemiology in the United States Using Papillary Thyroid Carcinoma Microsimulation Model

    Mar 1, 2024, 00:00 AM

  • Editorial Board

    Feb 26, 2024, 08:32 AM

  • Table of Contents

    Feb 1, 2024, 00:00 AM

  • Cost-Effectiveness of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the United States

    Feb 1, 2024, 00:00 AM

  • Cost-Effectiveness Analysis of Trastuzumab Deruxtecan Versus Trastuzumab Emtansine for Patients With Human Epidermal Growth Factor Receptor 2 Positive Metastatic Breast Cancer in the United States

    Feb 1, 2024, 00:00 AM

  • Patient Preferences in Pulmonary Arterial Hypertension, a Latent Class Analysis to Identify Preference Heterogeneity

    Feb 1, 2024, 00:00 AM

  • Applying Trial-Derived Treatment Effects to Real-World Populations: Generalizing Cost-Effectiveness Estimates When Modeling Complex Hazards [Editor's Choice]

    Feb 1, 2024, 00:00 AM

  • Systematic Review of Outcomes for Assessment of Medication Adherence Enhancing Interventions: An ISPOR Special Interest Group Report

    Feb 1, 2024, 00:00 AM

  • Establishing Meaningful Change Thresholds in Patient-Reported Outcomes Among Patients With Anaplastic Lymphoma Kinase-Positive Non–Small Cell Lung Cancer in ALTA-1L Trial

    Feb 1, 2024, 00:00 AM

  • Emulating Trials and Quantifying Bias: The Convergence of Health Technology Assessment Agency Real-World Evidence Guidance

    Feb 1, 2024, 00:00 AM

  • Health-Related Quality of Life of People Who Inject Drugs: The Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Engage Study

    Feb 1, 2024, 00:00 AM

  • Author Reply

    Feb 1, 2024, 00:00 AM

  • How Well Does the EQ-5D-Y-5L Describe Children With Intellectual Disability?: “There’s a Lot More to My Child Than That She Can’t Wash or Dress Herself.”

    Feb 1, 2024, 00:00 AM

  • Microsimulation Models on Mental Health: A Critical Review of the Literature [Editor's Choice]

    Feb 1, 2024, 00:00 AM

  • Influence of Self-Reported Health Impairments on German EQ-5D-5L Values

    Feb 1, 2024, 00:00 AM

  • The Health Inequality Impact of a New Cancer Therapy Given Treatment and Disease Characteristics

    Feb 1, 2024, 00:00 AM

  • Economic Burden and Service Utilization of Children With Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis

    Feb 1, 2024, 00:00 AM

  • Patient-Reported Outcome-Based Performance Measures in Alternative Payment Models: Current Use, Implementation Barriers, and Principles to Succeed [Editor's Choice]

    Feb 1, 2024, 00:00 AM

  • Editorial Board

    Jan 23, 2024, 09:13 AM

  • Editorial Board

    Jan 9, 2024, 12:13 PM

  • Assessing the Content Validity of Preference-Based Measures in Cancer

    Jan 1, 2024, 00:00 AM

  • Appropriate Categorization of Inequality to Inform Policy Decisions: Estimating Distribution of Lifetime Health Using Alternative Approaches to Socioeconomic Stratification [Editor's Choice]

    Jan 1, 2024, 00:00 AM

  • This Dead or That Dead: Framing Effects in the Evaluation of Health States

    Jan 1, 2024, 00:00 AM

  • A Scoping Review and Taxonomy of Epidemiological-Macroeconomic Models of COVID-19

    Jan 1, 2024, 00:00 AM

  • Multicriteria Decision Analysis and Value Assessment Frameworks: Where Do We Stand? What Next? [Editor's Choice]

    Jan 1, 2024, 00:00 AM

  • Remembering Victor R. Fuchs, the “Dean” of Health Economics

    Jan 1, 2024, 00:00 AM

  • Evaluation of Flexible Parametric Relative Survival Approaches for Enforcing Long-Term Constraints When Extrapolating All-Cause Survival [Editor's Choice]

    Jan 1, 2024, 00:00 AM

  • Central Venous Access Devices for the Delivery of Systemic Anticancer Therapy: An Economic Evaluation

    Jan 1, 2024, 00:00 AM

  • Testing 2 Alternative Time Trade-Off Methods for Valuation of Children’s Health States

    Jan 1, 2024, 00:00 AM

  • Analyzing Pragmatic Trials to Inform Cost-Effectiveness Analyses

    Jan 1, 2024, 00:00 AM

  • Multistakeholder Perceptions of Additional Value Elements for United States Value Assessment of Health Interventions [Editor's Choice]

    Jan 1, 2024, 00:00 AM

  • Negative Drug Pricing in the Context of Cost-Effectiveness Analysis: A Consistency Examination

    Jan 1, 2024, 00:00 AM

  • Economic Evaluations of Screening Programs for Chronic Kidney Disease: A Systematic Review

    Jan 1, 2024, 00:00 AM

  • Copyright/Subscription

    Jan 1, 2024, 00:00 AM

  • Characteristics of Prescription Drug Fills Using Pharmacy-Pharmacy Benefit Manager Discount Programs: The “GoodRx” Model

    Jan 1, 2024, 00:00 AM

  • Best Practices for the Electronic Implementation and Migration of Patient-Reported Outcome Measures

    Jan 1, 2024, 00:00 AM

  • Table of Contents

    Jan 1, 2024, 00:00 AM

  • Two Methods, One Story? Comparing Results of a Choice Experiment and Multidimensional Thresholding From a Clinician Preference Study in Aneurysmal Subarachnoid Hemorrhage [Editor's Choice]

    Jan 1, 2024, 00:00 AM

  • EE652 Assessing the Value of Digital Technologies: A Case Study on Humanoid Robot Assistance in Neurorehabilitation

    Dec 23, 2023, 13:57 PM

  • EE652 Assessing the Value of Digital Technologies: A Case Study on Humanoid Robot Assistance in Neurorehabilitation

    Dec 23, 2023, 13:57 PM

  • Editorial Board

    Dec 1, 2023, 08:12 AM

  • EPH252 A Systematic Review of the Global Burden of Endometriosis

    Dec 1, 2023, 00:00 AM

  • EE413 Economic and Humanistic Burden of Chronic Spontaneous Urticaria: A Systematic Literature Review

    Dec 1, 2023, 00:00 AM

  • EPH80 Survival and Best Recorded Response (BRR) in Patients With Advanced Merkel Cell Carcinoma (MCC): Analysis of a Prospective German MCC Registry Study (MCC TRIM) of the German Dermatologic Cooperative Oncology Group

    Dec 1, 2023, 00:00 AM

  • EPH230 Systematic Literature Review on the Clinical and Economic Burdens of Antimicrobial Resistance in the Japanese Population

    Dec 1, 2023, 00:00 AM

  • HSD2 Using Automated Data Extraction Methods to Understand the Evolution of Insulin Prescribing in the UK between 2021 and 2022

    Dec 1, 2023, 00:00 AM

  • EE566 Systematic Literature Review for Utility Data in Haemophilia

    Dec 1, 2023, 00:00 AM

  • EE486 Municipality Costs Due to COVID-19 Infections in Denmark: A Cost-of-Illness Study

    Dec 1, 2023, 00:00 AM

  • EE421 Cost-Effectiveness of Empagliflozin in Adult Patients with Chronic Kidney Disease in the Netherlands

    Dec 1, 2023, 00:00 AM

  • CO113 Impact of Clinical Pharmacist-Led Intervention on Somatic Cell Therapy Medicinal Product Circuit in Portugal

    Dec 1, 2023, 00:00 AM

  • PCR179 The Socio-Economic and Health-Related Quality of Life Impact of Myasthenia Gravis (MG) in Greece

    Dec 1, 2023, 00:00 AM

  • EE729 Early Intervention With Biosimilars Compared With Leflunomide in Established Rheumatoid Arthritis: A Cost-Effectiveness Analysis in Hong Kong

    Dec 1, 2023, 00:00 AM

  • SA34 The Cost-Effectiveness of Community Health Workers in Primary Health Care: A Systematic Literature Review

    Dec 1, 2023, 00:00 AM

  • MSR82 Combating Sample Scarcity: A Novel Bayesian Approach to Pediatric Basket Trials

    Dec 1, 2023, 00:00 AM

  • HTA181 How Can Health Technology Assessment Help in Addressing Drug Repurposing Challenges? A Conceptual Framework

    Dec 1, 2023, 00:00 AM

  • EE180 Comparing the Environmental Costs of Differentiated Service Delivery of Antiretroviral Therapy for People Living with HIV in Rural South Africa

    Dec 1, 2023, 00:00 AM

  • PCR144 Impact of Oral Corticosteroid Use on Health-Related Quality of Life: Analysis of EQ-5D Data from Navigator

    Dec 1, 2023, 00:00 AM

  • PCR212 A Novel Approach to Capturing Real-World Reasons Behind Use and Satisfaction of NVX-CoV2373 Booster Use Among German Adults: Direct-to-Patient Enrollment

    Dec 1, 2023, 00:00 AM

  • EE184 Lessons Learned from Model-Based Economic Evaluations of COVID-19 Treatments Under Pandemic Circumstances: Results from a Systematic Review

    Dec 1, 2023, 00:00 AM

  • RWD84 Building Federated Data Networks With Common Data Models to Generate Insights Through Real-World Evidence Observational Studies in Oncology

    Dec 1, 2023, 00:00 AM

  • HTA12 Focus on Two Years of Economic Opinions on Solid Cancers: What Are the Specific Features?

    Dec 1, 2023, 00:00 AM

  • EE665 Evaluation of Resource Use and Costs of Pertuzumab and Trastuzumab Formulations in HER2- Positive Breast Cancer

    Dec 1, 2023, 00:00 AM

  • EE605 Methodological Acceptability of the Economic Analyses Assessed by the HAS in 2022

    Dec 1, 2023, 00:00 AM

  • HTA209 A Review of the Differences Between the New EMA-EUnetHTA Joint Scientific Consultation Versus the Previous Ema-HTA Parallel Scientific Consultation

    Dec 1, 2023, 00:00 AM

  • HPR173 Supply-Side Stakeholders’ Opinions and Perspectives on the Development of Medical Tourism in the Region of Thessaly, Greece

    Dec 1, 2023, 00:00 AM

  • EE256 Economic Burden of Geographic Atrophy: A Systematic Review and Meta-Analysis

    Dec 1, 2023, 00:00 AM

  • HPR133 Analysis of Information Content on the Web Services About Antihypertensive Medicines in Ukraine

    Dec 1, 2023, 00:00 AM

  • PCR229 Achieving Increasingly Stringent Disease Control Criteria Was Associated with Greater Quality of Life Improvements in Patients with Active Psoriatic Arthritis: Results from BE OPTIMAL and BE COMPLETE/BE VITAL up to 1 Year

    Dec 1, 2023, 00:00 AM

  • EE225 Exploring the Value of Country-Specific Cost-Effectiveness Models in Early Stages of Drug Development

    Dec 1, 2023, 00:00 AM

  • EE193 Evaluating Clinical Benefits of Vertebral Body Stenting in Treating Osteoporotic Vertebral Compression Fracture: A Physician Survey

    Dec 1, 2023, 00:00 AM

  • EE551 Study of Costs of Hereditary Angioedema in Routine Clinical Practi Economic Impact of the Disease Burden in Spain

    Dec 1, 2023, 00:00 AM

  • MSR61 Existing Automated Tools to Assist Evidence Generation and Better Qualification of Registries and Real-World Data: A Systematic Review From the More-EUROPA Project

    Dec 1, 2023, 00:00 AM

  • SA47 Exploring the Use of Health Technology Assessment in Uganda’s Health Policy and Financing Decision-Making Processes

    Dec 1, 2023, 00:00 AM

  • SA24 Can an Integrated Systematic Literature Review (SLR) Database Improve the Speed of Title and Abstract (TIAB) Review? A Case Study Using Multiple Myeloma (MM) Projects in Interventional and Real-World Evidence (RWE) Evidence

    Dec 1, 2023, 00:00 AM

  • EE224 Out-of-Pocket Health Expenditures of Leukemia and Lymphoma Patients in Portugal

    Dec 1, 2023, 00:00 AM

  • RWD6 Costs of Dose Escalation Among Patients with Inflammatory Bowel Disease Treated with Vedolizumab and Ustekinumab in Portugal

    Dec 1, 2023, 00:00 AM

  • EPH254 Changes in Asthma-Related Healthcare Resource Use in Asthma Patients in the United States During the COVID-19 Pandemic

    Dec 1, 2023, 00:00 AM

  • EE328 Healthcare Costs in Patients With Hepatic Encephalopathy Receiving Rifaximin-α Treatment in the IMPRESS-II Study

    Dec 1, 2023, 00:00 AM

  • EE151 Trade-Off between Comparators Comprehensiveness and Methodological Robustness in Cost-Utility Studies Reviewed By Has in France

    Dec 1, 2023, 00:00 AM

  • MT60 Digital Health Applications (DIGA) in Germany—An Observation of Clinical Evidence Submissions

    Dec 1, 2023, 00:00 AM

  • HSD97 Exploring European Expert Opinion to Ensure Provision Outcomes in a Post-COVID World

    Dec 1, 2023, 00:00 AM

  • EPH265 Updated Estimations of the HPV Vaccination Deficit Among Girls in Gree Early Signs of Recovery?

    Dec 1, 2023, 00:00 AM

  • EE111 Indirect Cost Burden for Individuals Living with Transfusion-Dependent Beta-Thalassemia in Europe

    Dec 1, 2023, 00:00 AM

  • EE169 Novel Post-Processing Methods for Probabilistic Sensitivity Analysis in Cost-Effectiveness Models: Heat Map and Density-Based Clustering

    Dec 1, 2023, 00:00 AM

  • HPR217 Stakeholders' Perspectives on the Unmet Medical Need Concept: A EU Pharmaceutical Strategy Survey Analysis

    Dec 1, 2023, 00:00 AM

  • OP20 Carer Health-Related Quality of Life in Health Technology Assessments: Process Recommendations for Determining Relevance, Data Collection, and Inclusion in Health-Economic Models

    Dec 1, 2023, 00:00 AM

  • MSR60 Use of External Control Arms (ECAs) in Marketing Applications Submitted to European Medicines Agency (EMA): A Targeted Review

    Dec 1, 2023, 00:00 AM

  • HTA160 Development of a Web Application for Self-Assessment and Monitoring of Colorectal Surgery Outcome Indicators in the ESCA Study

    Dec 1, 2023, 00:00 AM

  • SA12 Discrepancy of Health State Utility Values in Cost-Utility Analyses of Interventions Against Infectious Diseases in Older Adults

    Dec 1, 2023, 00:00 AM

  • EE414 Incremental Costs of Abrocitinib Compared to Dupilumab for the Treatment of Moderate to Severe Atopic Dermatitis in Denmark

    Dec 1, 2023, 00:00 AM

  • EE520 Hospital Costs in Resected Patients With Early-Stage Non-Small Cell Lung Cancer (NSCLC): A French Real-World Retrospective Study Based on the National Hospitalization Database (PMSI)

    Dec 1, 2023, 00:00 AM

  • CO73 Overview of COA Measures in SLE Clinical Trials and Label Claims

    Dec 1, 2023, 00:00 AM

  • HTA47 An Overview of the Challenges in the HTA of Interventions Involving Healthcare Reorganisation

    Dec 1, 2023, 00:00 AM

  • MSR3 Comparing Statistical Adjustments to Correct Misclassification of Respiratory Syncytial Virus Infections (RSV) in Claims Data

    Dec 1, 2023, 00:00 AM

  • EE397 Determinants of Higher Cost and Inpatient Hospitalization Among Patients with AL Amyloidosis

    Dec 1, 2023, 00:00 AM

  • EE114 Reductions in Travel Time and CO2 Emissions Arising From Patient Transportation to Hospitals in Ireland for Treatment With Intravenous Iron: An Analysis Comparing Ferric Derisomaltose With Ferric Carboxymaltose

    Dec 1, 2023, 00:00 AM

  • HSD129 Does Digital Healthcare Improve the Utilization of Public Hospitals in the Emirate of Dubai?

    Dec 1, 2023, 00:00 AM

  • CO31 Progressive Pulmonary Fibrosis: A Modelling Analysis of Long-Term Progression Based on Inbuild

    Dec 1, 2023, 00:00 AM

  • EPH104 Human Papilloma Virus (HPV) Vaccination: Financial Impact and Recommendations

    Dec 1, 2023, 00:00 AM

  • EE350 Budget Impact of Memantine for Alzheimer's Patient in the United States

    Dec 1, 2023, 00:00 AM

  • SA29 Evaluating the Adherence to ISPOR Guidelines in Globally Published Budget Impact Analyses of New Drugs: A Targeted Literature Review

    Dec 1, 2023, 00:00 AM

  • PCR18 Humanistic Burden in Relapsed or Refractory (R/R) Follicular Lymphoma (FL): A Systematic Literature Review (SLR)

    Dec 1, 2023, 00:00 AM

  • HPR128 Addressing Bias in Health Applications: A Path Towards Health Equity

    Dec 1, 2023, 00:00 AM

  • SA64 Systematic Literature Review of Measurement and Valuation Methods for Societal Costs: A Focus on Cost-Effectiveness Analyses of Three Types of Disease Potentially Associated with High Spillover Effects

    Dec 1, 2023, 00:00 AM

  • EPH201 Epidemiology of Actinic Keratosis in Fran A General Population Survey (REAKT STUDY)

    Dec 1, 2023, 00:00 AM

  • RWD50 Evaluation and Improvement of a NHDS Algorithm to Detect Patients With Metastatic Breast Cancer and HER2+ Status Using a RWE NLP-Powered Solution

    Dec 1, 2023, 00:00 AM

  • SA31 Systematic Versus Rapid Reviews: The Impact of Different Methodologies on the Reviews’ Conclusions

    Dec 1, 2023, 00:00 AM

  • HSD90 Beyond the Hospital Walls: Hospital at Home Programs for Cancer Patients Worldwide and the Road to Implementation in Greece

    Dec 1, 2023, 00:00 AM

  • HTA97 Exploring the Value of RWD Collected From Early Access Programs to Support HTA Decision-Making

    Dec 1, 2023, 00:00 AM

  • EE508 Cost Estimation Model of Prevented Recurrences with Atezolizumab in Early Non-Small Cell Lung Cancer in Italy

    Dec 1, 2023, 00:00 AM

  • HSD132 Analysis of Factors Affecting Medication Adherence in Patients with Hypertension in South Korea

    Dec 1, 2023, 00:00 AM

  • EPH169 Examination of the Quality of Life of Patients Underwent Ischemic Stroke and Treated With Intravenous Thrombolytic and Mechanical Thrombectomy Recanalization Intervention

    Dec 1, 2023, 00:00 AM

  • HTA255 First-in-Class Drugs in HTA: Blunder or Bliss?

    Dec 1, 2023, 00:00 AM

  • SA17 Application of CPRD Data in NICE Submissions: Model Inputs for Functional Health States

    Dec 1, 2023, 00:00 AM

  • HTA86 Factors Affecting Time to Reimbursement of Novel Anticancer Drugs in Ireland

    Dec 1, 2023, 00:00 AM

  • EE276 Cost-Effectiveness Analysis of Dupilumab for the Treatment of Prurigo Nodularis in Adult Patients in Italy

    Dec 1, 2023, 00:00 AM

  • PCR273 Perceptions, Attitudes, and Satisfaction with Private Pharmacies in Gree Results from a Nationwide Survey

    Dec 1, 2023, 00:00 AM

  • EE78 A Cost-Effectiveness Analysis of Atezolizumab as Adjuvant Treatment Following Complete Resection and Platinum-Based Chemotherapy in Adult Patients With Early-Stage Non-Small Cell Lung Cancer With a High Risk of Recurrence

    Dec 1, 2023, 00:00 AM

  • EPH103 Estimating the Burden of Vaccine-Preventable Respiratory Diseases Without Vaccination Alternatives in Europe: What's Going on in Spain and Germany?

    Dec 1, 2023, 00:00 AM

  • EPH50 Impact of Dispensed Medication on Mean Age of Death: A Brazilian Public Health System Study

    Dec 1, 2023, 00:00 AM

  • RWD21 Impact of Haemophilia Severity on Healthcare Resource Usage: Results from a Multinational Real-World Survey

    Dec 1, 2023, 00:00 AM

  • EE505 Cost-Effectiveness of Ofatumumab in Treatment of Relapsing Multiple Sclerosis in Turkey

    Dec 1, 2023, 00:00 AM

  • EE317 Microsimulation Model in Obesity: A Feasibility Study Using Object-Oriented C++ Code

    Dec 1, 2023, 00:00 AM

  • CO112 Clinical Characteristics and Quality of Life of Thai Moderate to Severe Psoriasis Patients Before Initiating Secukinumab: An Interim Analysis from Prompt Study

    Dec 1, 2023, 00:00 AM

  • HTA288 How Wide Ranging Is the Implementation of HTA and Cost-Effectiveness Assessment (CEA) in Major Healthcare Markets

    Dec 1, 2023, 00:00 AM

  • EPH101 Assessing the Relative Benefits Associated With Developing Vaccines for Nipah Virus Infection and Rift Valley Fever From Local, National, and Global Perspectives

    Dec 1, 2023, 00:00 AM

  • HPR74 Analysis of the Guangdong-Hong Kong-Macau Greater Bay Area Urgent-Use Medicine Scheme—An Opportunity for Early Access in Mainland China

    Dec 1, 2023, 00:00 AM

  • PCR130 Factors Associated With Adjuvant Treatment Options in Resected Stage III Melanoma, From a Patient and Physician Perspective: Preference Assessment Using the Discrete Choice Experiment Method (Pamela Study)

    Dec 1, 2023, 00:00 AM

  • HTA122 How Has NICE's Severity Modifier Been Implemented?

    Dec 1, 2023, 00:00 AM

  • HPR169 The Impact of Exercise on Health Expenditure in Children

    Dec 1, 2023, 00:00 AM

  • HPR15 Review and Evaluation of Health Equity Considerations in Health Technology Assessments in Cystic Fibrosis

    Dec 1, 2023, 00:00 AM

  • MT35 The Impact of Patient Engagement with a Digital Diabetes Solution on All-Cause Healthcare Resource Utilization Rates and Charges

    Dec 1, 2023, 00:00 AM

  • HSD114 Treatment Patterns and Adverse Events (AEs) in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in France, Italy, and the United Kingdom (UK)

    Dec 1, 2023, 00:00 AM

  • EE188 A Retrospective Cohort Comparing the Tuberculosis Diagnosis Related Costs and Health Resource Use (HRU) Using a Rapid Nucleic Acid Amplification (NAA) Test Vs. Conventional Tests in China, Followed By a Budget Impact Model

    Dec 1, 2023, 00:00 AM

  • SA56 Treatment Patterns of Advanced Egfr-Positive Non-Small Cell Lung Cancer (NSCLC) in Latin America

    Dec 1, 2023, 00:00 AM

  • EPH155 Burden of Clinical Syndromes Associated with Pneumococcal Disease in Peru: A 2019 Perspective

    Dec 1, 2023, 00:00 AM

  • MT52 Economic and Organizational Advantages of Mrgfus for the Treatment of Essential Tremor in Italy

    Dec 1, 2023, 00:00 AM

  • EE292 Cost Effectiveness Analysis of Recombinant Zoster Vaccine Among 50 Years Old and Older in Sweden

    Dec 1, 2023, 00:00 AM

  • RWD72 Status of the Art on Global Clinical Trials of Patient-Managed Digital Medical Devices (pDMD): 2023 Original Data Analysis From Multiple Sources

    Dec 1, 2023, 00:00 AM

  • RWD60 APNEE Study: A Challenge to Identify Patients Treated with Dupilumab for Chronic Rhinosinusitis with Nasal Polyps (CRSWNP) in Real-Life Settings in France

    Dec 1, 2023, 00:00 AM

  • HPR182 Oncology Combination Market Access Conundrum in Europe

    Dec 1, 2023, 00:00 AM

  • EPH248 Varying Latency Impact on Incidence of Second Primary Malignancy Among Patients with B-Cell Malignancy

    Dec 1, 2023, 00:00 AM

  • EE415 Effect of Vitamin C Use on Cost of Common Cold in Turkiye

    Dec 1, 2023, 00:00 AM

  • EE481 Cost-Effectiveness Analysis of Upadacitinib in Patients with Moderately to Severely Active Ulcerative Colitis in Greece

    Dec 1, 2023, 00:00 AM

  • CO54 Recurrence-Free Survival (RFS) as a Surrogate Endpoint (SE) for Overall Survival (OS) in Resected Stage II/III Melanoma: A Correlation Meta-Analysis of Randomized Controlled Trials (RCTs)

    Dec 1, 2023, 00:00 AM

  • RWD122 First and Second Line Treatment Choices for Endometrial Cancer: ECHOS-A Real-World Study

    Dec 1, 2023, 00:00 AM

  • CO20 Use of Inpatient Systemic Chemotherapy and/or Radiotherapy and Related Predictive Factors for Metastatic Urothelial Cancer (mUC): Findings from a Retrospective Observational Study in a Clinical Practice Setting in Italy

    Dec 1, 2023, 00:00 AM

  • HPR218 Recent Advances in Voluntary European Cross-Border Collaborations in Joint HTA and Drug Pricing/Procurement

    Dec 1, 2023, 00:00 AM

  • EE139 The Need for Economic Systems Modelling to Assess the True Value of Healthcare Innovations: An Application to Influenza Vaccinations

    Dec 1, 2023, 00:00 AM

  • RWD120 Analysis of the Impact of National Medical Insurance Negotiation Policy on the Accessibility of Anti-Cancer Drugs in a City in China

    Dec 1, 2023, 00:00 AM

  • HSD57 Adherence Teleassistance-Based Program Impact in a Real-Life Diabetes Colombian Patient Cohort

    Dec 1, 2023, 00:00 AM

  • HSD31 Impact and Management of Comorbidities in People With Obesity: A Multinational Survey

    Dec 1, 2023, 00:00 AM

  • MT69 Early Health Economic Modelling to Support the Development of Lifechamps Digital Platform for Older Cancer Survivors

    Dec 1, 2023, 00:00 AM

  • HTA352 The Significance of Literature Reviews in the Process of Decision-Making by the Haute Autorité De Santé

    Dec 1, 2023, 00:00 AM

  • EE733 Distributional Cost-Effectiveness Analysis: A Case Study on Its Potential Prospects in HTA

    Dec 1, 2023, 00:00 AM

  • MSR90 Is the Current Chatgpt Able to Gatherarticles for HEOR Literature Review

    Dec 1, 2023, 00:00 AM

  • EE542 Assessment of the Cost-Effectiveness of Risk Factor Guided Prophylaxis with Palivizumab for the Prevention of Severe Respiratory Syncytial Virus Infection in Colombian Infants Born at 32–35 Weeks’ Gestational Age

    Dec 1, 2023, 00:00 AM

  • PCR41 The Impact of Moderate to Severe Chronic Hand Eczema and the Effect of Improved Clinical Symptoms on Work Productivity Loss: Data from the DELTA 1 and DELTA 2 Phase 3 Trials

    Dec 1, 2023, 00:00 AM

  • MSR65 The Impact of Censoring Assumptions in the Generation of Individual Patient Data from Kaplan-Meier Estimates

    Dec 1, 2023, 00:00 AM

  • PCR52 Use of Patient Reported Outcomes in Key Trials Supporting Marketing Authorisation: 5-Year Analysis of Company Evidence Submitted for National Institute for Health and Care Excellence (NICE) Single Technology Appraisal (STA)

    Dec 1, 2023, 00:00 AM

  • EE327 Cost-Effectiveness of Teduglutide in Adult and Pediatric Patients with Short Bowel Syndrome in Argentina: A Markov Model Analysis

    Dec 1, 2023, 00:00 AM

  • CO100 Regular Laboratory Checks for Ileostomy Patients After Surgery Are Not Performed Comprehensively, but Could Result in Better Health Outcomes

    Dec 1, 2023, 00:00 AM

  • EPH148 Disease Burden of Sickle Cell Disease in Saudi Arabia

    Dec 1, 2023, 00:00 AM

  • HTA18 Challenges of Identifying Health Utility Data for Patients With Penta-Refractory Multiple Myeloma to Inform HTA Reimbursement Discussion for Newer Treatment Options

    Dec 1, 2023, 00:00 AM

  • PCR261 Uncovering Patient-Reported Outcome Differences Between Undiagnosed and Diagnosed Individuals With Moderate to Severe Psoriasis in Europe

    Dec 1, 2023, 00:00 AM

  • MT18 Endovascular Management of Iliac and Aorto-Iliac Aneurysms and Impact on Morbidity/Mortality in Fran A French National Insurance Claims Database Analysis (SNDS)

    Dec 1, 2023, 00:00 AM

  • PCR138 An International Study of Patient and Caregiver-Reported Burden and Quality of Life in Wiskott-Aldrich Syndrome

    Dec 1, 2023, 00:00 AM

  • SA49 Capturing Real-World Evidence Alongside Trial Evidence in HTA-Specified Systematic Literature Review: Optimizing Search Strategies across the Totality of Evidence Required

    Dec 1, 2023, 00:00 AM

  • PCR153 Pace CKD: The Impact of Chronic Kidney Disease and Dialysis on Caregivers Financial Status, and Work Productivity: Results from a Multinational Survey

    Dec 1, 2023, 00:00 AM

  • HPR5 Implementing a Value-Based Payment Model for Patients with Osteoarthritis

    Dec 1, 2023, 00:00 AM

  • EPH212 The Acceptability of Human Papillomavirus Vaccination in the United Kingdom: A Review of the Literature on Barriers and Facilitators to Vaccination

    Dec 1, 2023, 00:00 AM

  • EE648 Systematic Review of the Cost Effectiveness of Newborn Screening for Spinal Muscular Atrophy

    Dec 1, 2023, 00:00 AM

  • EPH167 The Conceptualization of Cardiometabolic Disease Policy Model in the UK

    Dec 1, 2023, 00:00 AM

  • EE182 Costs and Health Impact of Wastewater Surveillance to Guide Respiratory Syncytial Virus Prophylaxis in Canada, Compared to Clinical Surveillance

    Dec 1, 2023, 00:00 AM

  • PCR247 Is the Symptomatology of Infantile Tay-Sachs and Infantile Sandhoff Disease Identical? Data from an International Registry

    Dec 1, 2023, 00:00 AM

  • RWD156 Real-World Progression Patterns in First and Second Lines of Systemic Therapy for Endometrial Cancer

    Dec 1, 2023, 00:00 AM

  • EE687 Cost Analysis of Prostav®: A New Telomere-Based Biomarker for the Early Detection of Prostate Cancer Available in Europe

    Dec 1, 2023, 00:00 AM

  • EE270 Predicting Persistent Severe Acute Kidney Injury (AKI) Using the Urinary C-C Motif Chemokine Ligand 14 Biomarker (CCL14). Cost-Utility Analysis in Spain and the UK

    Dec 1, 2023, 00:00 AM

  • HTA39 A Valuable Perspective on Medical Devices – Assesing the Organizational Impact of Health Technologies in Decision-Making

    Dec 1, 2023, 00:00 AM

  • EE439 Public Health Impact of the Pediatric Immunization Program in the Netherlands

    Dec 1, 2023, 00:00 AM

  • PCR204 Impact of Roflumilast Foam 0.3% on Patient-Reported Quality of Life in Seborrheic Dermatitis: An Analysis of Stratum Data for Patients Unresponsive or Intolerant to Topical Corticosteroids

    Dec 1, 2023, 00:00 AM

  • HPR202 The Digital Transformation: How Could Artificial Intelligence (AI) Re-Shape Drug Launch?

    Dec 1, 2023, 00:00 AM

  • HTA46 Relationship Between the Directness of the Evidence and Identification of Added Therapeutic Value: An Analysis of HTA Procedures

    Dec 1, 2023, 00:00 AM

  • EPH19 Mental Health Disparities for Young Adults with Arrest Histories in the United States

    Dec 1, 2023, 00:00 AM

  • HTA152 Multidimensional Evaluation of Inebilizumab in Patients With Neuromyelitis Optica Spectrum Disorder

    Dec 1, 2023, 00:00 AM

  • HPR107 Bilateral Price Comparison of 50 Particularly Cost-Intensive Drugs – What Is the Impact of Different Reimbursement Rules?

    Dec 1, 2023, 00:00 AM

  • HPR163 Underinvestment in Pharmaceutical Care and Unmet Pharmaceutical Needs Among Older European Adults

    Dec 1, 2023, 00:00 AM

  • HTA278 Risky Business: How Does Risk of Study Bias Impact Health Technology Assessment Submissions?

    Dec 1, 2023, 00:00 AM

  • EE573 Economic Burden of Chronic Kidney Disease with Type 2 Diabetes in Turkiye

    Dec 1, 2023, 00:00 AM

  • SA21 Feasibility Assessment of an Indirect Treatment Comparison (ITC) of Sacituzumab Govitecan (SG) Vs Trastuzumab Deruxtecan (T-DxD) in HR+/HER2– Metastatic Breast Cancer (mBC)

    Dec 1, 2023, 00:00 AM

  • Economic Evaluation

    Dec 1, 2023, 00:00 AM

  • MSR98 Generate Synthetic Data in R for a Hypothetical Alzheimer's Disease Trial

    Dec 1, 2023, 00:00 AM

  • RWD150 A Prescription Pattern of HIV First-Line Tenofovir Alafenamide-Based Single-Tablet Regimens: A Multi-Institutional Study in Taiwan

    Dec 1, 2023, 00:00 AM

  • HTA9 Success Rate of Cancer Drugs Fund Reappraisals

    Dec 1, 2023, 00:00 AM

  • EE390 Optimizing the Use of Risk Factors to Guide the Cost-Effective Use of Palivizumab Prophylaxis Against Severe Respiratory Syncytial Virus Infection in Korean Infants Born 32–35 Weeks’ Gestational Age

    Dec 1, 2023, 00:00 AM

  • SA27 Menopause: More Than Just Vasomotor Symptoms

    Dec 1, 2023, 00:00 AM

  • RWD132 Impact of Exacerbations on Disease Burden of COPD: A Retrospective Observational Database Cohort Study in Tianjin, China

    Dec 1, 2023, 00:00 AM

  • EE724 Inside CKD: Projecting the Population Level Economic Burden of Chronic Kidney Disease According to Urine Albumin-to-Creatinine Ratio (uACR) Categories

    Dec 1, 2023, 00:00 AM

  • HTA4 The Challenges of Health Economic Modeling for Mental Health, Behavioral, and Neurodevelopmental Conditions

    Dec 1, 2023, 00:00 AM

  • HTA290 Environmental Sustainability in HTA: Are HTA Bodies Applying Environmental Criteria in Their Decision-Making?

    Dec 1, 2023, 00:00 AM

  • HSD47 Value for Money of Multidisciplinary Programs for Integrated Care in Dialysis: Being Actively Involved and No Merely Listed Matters

    Dec 1, 2023, 00:00 AM

  • EE254 Budget Impact of Telemonitoring (TM)-Enabled Care of Obstructive Sleep Apnea Hypoanpnea Syndrome (OSAH) in the UK

    Dec 1, 2023, 00:00 AM

  • CO175 OCTOPUS: Ambispective Observational Study Describing Diagnosis and Treatment Patterns in Adults with Metastatic NSCLC with BRAF V600E Mutation in Clinical Practice, to Assess Treatment Effectiveness and Quality of Life (TIP)

    Dec 1, 2023, 00:00 AM

  • EPH154 Modeled Head-to-Head Comparison of Nirsevimab and Rsvpref Maternal Vaccine in the US

    Dec 1, 2023, 00:00 AM

  • HTA117 A Comparison of Health Technology Appraisal (HTA) Timelines and Requirements for Orphan Technologies in 10 European Countries

    Dec 1, 2023, 00:00 AM

  • Reflecting Parameter Uncertainty in Addition to Variability in Constrained Healthcare Resource Discrete Event Simulations: Worth Going the Extra Mile or a Road to Nowhere?

    Dec 1, 2023, 00:00 AM

  • SA83 {Maicplus}: An R Package to Support Analysis and Reporting of Matching Adjusted Indirect Treatment Comparisons (MAIC) for HTA Dossiers

    Dec 1, 2023, 00:00 AM

  • EPH207 The Adverse Event Profiles of Modafinil in Approved Indications and Off-Label Use for Major Depressive Disorder: A Systematic Review and Meta-Analysis

    Dec 1, 2023, 00:00 AM

  • HTA174 Single-Arm Studies in Rare Diseases and Statistical Methods to Mitigate Lack of Comparative Data: What Kind of Assessment Is More Successful for the French HTA Body?

    Dec 1, 2023, 00:00 AM

  • HTA71 Bridging the Gap: Exploring the PICO Vs Estimand Frameworks in EU Health Technology Assessment (HTA)

    Dec 1, 2023, 00:00 AM

  • MSR147 Accounting for Study Heterogeneity When Modelling the Multi-State Natural History of Rare Diseases

    Dec 1, 2023, 00:00 AM

  • EE60 An Overview of Systematic Reviews of Economic Evaluations on Cancer Screening: Landscape, Quality, and Recommendations

    Dec 1, 2023, 00:00 AM

  • EE445 Economic Evaluation of Alternative Measles-Mumps-Rubella Childhood Vaccination Schedules in Denmark

    Dec 1, 2023, 00:00 AM

  • OP7 Coverage and Equity of a Patient Support Program for Diabetes During the Pandemic Period in a Middle-Income Country

    Dec 1, 2023, 00:00 AM

  • HTA313 The Same but Different: Inconsistencies in Key Cost-Effectiveness Assumptions for Curative Therapies across Clinically Similar NICE Appraisals

    Dec 1, 2023, 00:00 AM

  • EE594 Comparison of the Clinical and Economic Impact of Two COVID-19 Vaccines in Immunocompromised Patients in France

    Dec 1, 2023, 00:00 AM

  • HTA14 Expanding the HTA Cost-Effectiveness Analyses for CheckMate 9LA: Nivolumab Plus Ipilimumab Plus Chemotherapy As First-Line Strategy for Non-Small Cell Lung Cancer

    Dec 1, 2023, 00:00 AM

  • HTA104 Data on Patient-Reported Outcomes Is Not a Prerequisite for Achieving an Additional Benefit in German Early Benefit Assessment of New Medicinal Products Approved for Dermatological Diseases

    Dec 1, 2023, 00:00 AM

  • HPR46 Payers’ Perceptions of Current Policy Approaches to Address Antimicrobial Resistance in Europe

    Dec 1, 2023, 00:00 AM

  • HSD36 Impact of Non-Medical Factors on Patterns of Treatment in Patients With Cancer: A Systematic Literature Review

    Dec 1, 2023, 00:00 AM

  • MSR130 Current Trends in Quantitative Bias Analysis for Unmeasured Confounders: A Targeted Literature Review

    Dec 1, 2023, 00:00 AM

  • EPH125 A Systematic Literature Review and Meta-Analysis on the Disease Burden of Chikungunya

    Dec 1, 2023, 00:00 AM

  • EE341 Cost-Utility Analysis of a Multi-Center, Parallel Group Randomized Controlled Trial of an Adapted Parenting Intervention (EPICC-ID) to Reduce Challenging Behavior in Pre-Schoolers with Moderate to Severe Intellectual Disability

    Dec 1, 2023, 00:00 AM

  • EPH21 An Assessment of Validated Algorithms for Identifying Multiple Sclerosis Cases, Subtypes, and Relapses in Real-World Databases: A Systematic Review

    Dec 1, 2023, 00:00 AM

  • HTA83 Economic Evaluations in Relapsed or Refractory (R/R) Follicular Lymphoma (FL): Challenges for Health Technology Assessment (HTA) Submissions

    Dec 1, 2023, 00:00 AM

  • EPH196 Prevalence of GI Comorbidities by Age Group Among Patients With Rett Syndrome: An Analysis of Coded EHR and Pharmacy Data and Clinical Notes

    Dec 1, 2023, 00:00 AM

  • EE393 The Cost-Effectiveness of Atidarsagene Autotemcel (Arsa-Cel) for the Treatment of Metachromatic Leukodystrophy (MLD) in the US

    Dec 1, 2023, 00:00 AM

  • HSD130 Development of a Risk-Adjusted in-Hospital Complication Rate (RAICR) Using Machine Learning Methods

    Dec 1, 2023, 00:00 AM

  • HSD105 Pharmacists' Intervention in Access to Therapeutical Innovation in Portuguese Hospitals

    Dec 1, 2023, 00:00 AM

  • P7 International Reference Pricing and Joint Clinical Assessments—How Will European-Level HTA Evaluations Impact International Reference Pricing and Launch Sequencing?

    Dec 1, 2023, 00:00 AM

  • HPR152 Evolution of the Use of Medicines in Special Situations and Management Measures for Their Rational Use

    Dec 1, 2023, 00:00 AM

  • HPR9 Value Criteria for Outcomes Based Managed Entry Agreement of CAR-T in Relapsed or Refractory Multiple Myeloma (RRMM) through MCDA

    Dec 1, 2023, 00:00 AM

  • HPR165 Financial-Based Managed Entry Agreements for Drugs in Romania: From Simple to Complex

    Dec 1, 2023, 00:00 AM

  • EPH161 Epidemiology Landscape and Impact of Obesity: Multi-Country Results from the Impact-O Study

    Dec 1, 2023, 00:00 AM

  • EE583 Unraveling Modeling Challenges in the Economic Evaluations of Gene Therapies: A Global Review

    Dec 1, 2023, 00:00 AM

  • EPH44 Temporary Soft Tissue Coverage in Burn Patients - Which Materials Are Used - and By Whom? Analysis of German Billing Data

    Dec 1, 2023, 00:00 AM

  • RWD5 Body Fatness Associations with Cancer: Retrospective Cohort Study from a Brazilian Health Management Organization (RWE)

    Dec 1, 2023, 00:00 AM

  • RWD143 Beyond Accuracy: Automated De-Identification of Large Real-World Clinical Text Datasets

    Dec 1, 2023, 00:00 AM

  • MT12 Comparison of Hospital Case Characteristics of Popliteal Artery Aneurysm Repair with ePTFE Covered Stent Grafts with a Heparin Bioactive Surface and Open Surgical Bypass: Highlights from the 2021 Hospital Dataset in Germany

    Dec 1, 2023, 00:00 AM

  • PCR16 Uncovering the Influence of Smoking on Health Care Processes for Adult Lung Cancer Patients in Chile: Insights From a Multi-Perspective Qualitative Study

    Dec 1, 2023, 00:00 AM

  • PCR263 Design of a Patient-Informed Chronic Kidney Disease (CKD) Experience Interview Guide: Learnings From DISCOVER CKD

    Dec 1, 2023, 00:00 AM

  • EPH260 Rare Diseases and Kidney Stones: Are Stones in Amino Acid Transport Disorders Special?

    Dec 1, 2023, 00:00 AM

  • HTA259 Exploring Collaboration on HTA Methodology for Medical Technologies in the Dutch ZonMw HTA Methodology 2021-2024 Subsidy Program

    Dec 1, 2023, 00:00 AM

  • HPR207 Moving to Outcomes-Based Agreements in Algeria: Sharing Experiences Between Saudi Arabia and Algeria

    Dec 1, 2023, 00:00 AM

  • EE66 Cost Effectiveness Analysis of Pembrolizumab as First-Line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer in Greece

    Dec 1, 2023, 00:00 AM

  • PCR83 Fibrodysplasia Ossificans Progressiva (FOP): The Patient Experience

    Dec 1, 2023, 00:00 AM

  • PCR119 The CaOa-QoL-TS: Development and Validation of an Owner-Completed Health-Related Quality of Life and Treatment Satisfaction Measure in Canine Osteoarthritis

    Dec 1, 2023, 00:00 AM

  • CO37 Inventory-Facilitated Goal Setting Interview Conducted by Disease Experts Yields a Broader Range of Goal Areas

    Dec 1, 2023, 00:00 AM

  • EE440 Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine in Indian Adults Aged ≥60 Years

    Dec 1, 2023, 00:00 AM

  • EPH132 Epidemiology of Breast and Cervical Cancer in Women of the Colombian Caribbean Region During 2018-2021

    Dec 1, 2023, 00:00 AM

  • HPR204 Reimbursement Status of Centrally Authorized Drugs in Spain per Therapeutic Area and Orphan Designation

    Dec 1, 2023, 00:00 AM

  • EE107 Estimating EQ-5D Utilities From the Facial Vitiligo Area Scoring Index (F-VASI) in Vitiligo Patients Using a Mapping Algorithm Applied to 2 Pooled Randomized Controlled Trials

    Dec 1, 2023, 00:00 AM

  • MSR73 Methods for Incorporating External Eviden A Comparison of Their Impact on Extrapolations and Uncertainty Estimates Using a Melanoma Case-Study

    Dec 1, 2023, 00:00 AM

  • MSR52 Defining Severity Category Thresholds to Guide Psoriasis Symptoms and Impacts Measure Score Interpretation Using Pooled Data from Three Phase 3 Trials in Plaque Psoriasis

    Dec 1, 2023, 00:00 AM

  • CO83 Disease Burden of Moderate to Severe Ulcerative Colitis in Chinese Patients Under Current Care: A Model Simulation Study

    Dec 1, 2023, 00:00 AM

  • CO4 Overview of Recent Systematic Literature Reviews on Glucagon-like Peptide-1 Receptor Agonists for Weight Loss in Adults with Obesity

    Dec 1, 2023, 00:00 AM

  • HTA184 Review of HTA Evaluation for Gene Therapies and Their Future Implications in Europe

    Dec 1, 2023, 00:00 AM

  • CO146 Language Model-Based Approach for Extracting Comorbidities and Complications in Fabry Disease Clinical Notes

    Dec 1, 2023, 00:00 AM

  • EE69 Cost-Utility Analysis of Lorlatinib for First-Line Treatment for ALK Positive Advanced Non-Small Cell Lung Cancer in China

    Dec 1, 2023, 00:00 AM

  • PCR253 The Burden of Persistent Cough in Idiopathic Pulmonary Fibrosis (IPF) and Other Interstitial Lung Diseases (ILD): A Systematic Evidence Synthesis

    Dec 1, 2023, 00:00 AM

  • Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0

    Dec 1, 2023, 00:00 AM

  • MSR37 Validation of the Ibadan Knee/Hip Osteoarthritis Outcome Measure (IKHOAM) Among Patients With Knee Osteoarthritis

    Dec 1, 2023, 00:00 AM

  • CO89 Efficacy of Anti-Alzheimer’S (AD) Drugs in Cognitive Improvement: A Network Meta-Analysis (NMA) of Randomized Controlled Trials (RCTS)

    Dec 1, 2023, 00:00 AM

  • HPR45 Trends in Semaglutide Prescribing and Dispensing – a Nationwide Register-Based Study

    Dec 1, 2023, 00:00 AM

  • PCR254 Building a COA Strategy in Chronic Rhinosinusitis with or Without Nasal Polyps: Patient Experiences and Clinical Outcome Assessments from the Literature

    Dec 1, 2023, 00:00 AM

  • PCR54 Knowledge, Attitudes and Practices of Patients Towards Generics in Greece

    Dec 1, 2023, 00:00 AM

  • Medication Use and Its Consequences

    Dec 1, 2023, 00:00 AM

  • EE521 Economic Evaluation of Trastuzumab Deruxtecan for HER2+ Advanced Gastric Cancer Patients

    Dec 1, 2023, 00:00 AM

  • HTA73 Health Technology Assessment (HTA) Timelines Analysis in the Post-COVID Era: Comparison of HTA Process Duration in the First Half (H1) of 2023 to H1 2022

    Dec 1, 2023, 00:00 AM

  • PT4 Patient-Reported Outcomes (PROs) in German AMNOG-Assessments: Impact of Increasing the Response Threshold to 15 %

    Dec 1, 2023, 00:00 AM

  • EPH106 Intercultural Approach and Knowledge of Migrant Health Policy in Healthcare Teams and Migrants in Chile

    Dec 1, 2023, 00:00 AM

  • EE4 Cost-Effectiveness of Andexanet Alfa Versus Prothrombin Complex Concentrate Is Likely for the Treatment of Factor Xa Inhibitor–Related Major Bleeds in the Netherlands

    Dec 1, 2023, 00:00 AM

  • HSD87 Physician Reported Reasons for Cidp Treatment Choice across 5 European Countries: Results from a Real-World Survey

    Dec 1, 2023, 00:00 AM

  • PCR258 Baseline Demographic and Clinical Characteristics of Patients with Plaque Psoriasis Treated with Brodalumab in the Canadian Real-World Setting: Results from the Care Study

    Dec 1, 2023, 00:00 AM

  • EE178 A Targeted Literature Review of Cost-Utility Analyses for Ulcerative Colitis/Crohn’s Disease Treatment

    Dec 1, 2023, 00:00 AM

  • RWD9 Identifying Predictors of Response Following Discontinuation of JAKi Therapy in Patients with Rheumatoid Arthritis

    Dec 1, 2023, 00:00 AM

  • EE448 Exploring Non-Patient Utilities Using Time Trade-Off Exercises in the UK General Population

    Dec 1, 2023, 00:00 AM

  • HTA211 Requirements for Economic Evaluations for Health Technology Assessment Submissions across Different Countries

    Dec 1, 2023, 00:00 AM

  • EPH61 Epidemiology of Tumor-Related Hypothalamic Obesity in Germany—A Representative Claims Data Analysis

    Dec 1, 2023, 00:00 AM

  • EPH198 Annual Health Insurence Treatment Cost of Polycystic Ovary Sindrome Based on Routinely Collected Financing Data Between 2010-2019

    Dec 1, 2023, 00:00 AM

  • EE280 The Lean Assessment Process (LAP) Methodology: An Iterative and Multi-Disciplinary Method for Identifying Clinical Needs, Assessing Technology Acceptance, a Precursor for Early Economic Evaluation and Adoption Strategies

    Dec 1, 2023, 00:00 AM

  • MT43 Does Real-World Evidence Play a Role in Decision-Making by HTA Bodies for Medical Technologies?

    Dec 1, 2023, 00:00 AM

  • EPH184 The Relevance of Insomnia in Relation to Other High-Impact Pathologies. a Systematic Literature Review

    Dec 1, 2023, 00:00 AM

  • EE396 Economic Evaluation of PD-1 Blockers in Merkel Cell Carcinoma: A Systematic Literature Review

    Dec 1, 2023, 00:00 AM

  • EPH14 Burden of Respiratory Syncytial Virus Infection in Germany: A Systematic Review

    Dec 1, 2023, 00:00 AM

  • P44 Seeing it in the Flesch: Comparing Readability Between AI-Generated and Human-Written Plain-Language Abstracts

    Dec 1, 2023, 00:00 AM

  • EE418 Cost-Utility Analysis of Ferric Derisomaltose Versus Ferric Carboxymaltose in Treating Iron Deficiency Anemia in Norwegian Patients With Inflammatory Bowel Disease

    Dec 1, 2023, 00:00 AM

  • OP15 Analysis of the Multidisciplinary Approach for the Management of Patients Affected by Waldenstrom's Macroglobulinemia, Marginal Zone Lymphoma and Chronic Lymphocytic Leukemia in Italy

    Dec 1, 2023, 00:00 AM

  • HSD22 Vaccine Preparation Time, Cost, and Preference Comparison Between Pre-Filled Syringe Formulations and Vaccines That Require Reconstitution: A Targeted Literature Review

    Dec 1, 2023, 00:00 AM

  • CO71 Faricimab Versus Standard of Care in Naive Neovascular Age-Related Macular Degeneration Patients: An Indirect Treatment Comparison Using Individual Level Data

    Dec 1, 2023, 00:00 AM

  • EPH90 The Increasing Incidence of Respiratory Syncytial Virus (RSV) in Ireland

    Dec 1, 2023, 00:00 AM

  • EE730 Modelling Considerations for Evaluating the Cost-Effectiveness of Biologics in Eosinophilic-Associated Diseases

    Dec 1, 2023, 00:00 AM

  • EE490 Analysis of Access and Avalibility of Low Molecular Heparins for the Treatment of COVID-19 during Wartime in Ukraine

    Dec 1, 2023, 00:00 AM

  • PCR182 Patient Preferences for Tumor-Agnostic Therapies: Qualitative Insights and Challenges

    Dec 1, 2023, 00:00 AM

  • HTA246 A QALY Is Not a QALY When It Comes to Health Technology Appraisals of Pediatric Rare Diseases

    Dec 1, 2023, 00:00 AM

  • EE717 Healthcare Resource Utilization Among Patients with Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in France

    Dec 1, 2023, 00:00 AM

  • HSD80 Employees Satisfaction Working at Arta General Hospital of Greece

    Dec 1, 2023, 00:00 AM

  • HTA178 Using Mixed-Methods Development-Focused HTA and Npv Calculations to Guide Further Investment and RD: A Case Study on Establishing the Value Proposition for Biosensor-Integrated Self-Reporting Arteriovenous Grafts

    Dec 1, 2023, 00:00 AM

  • EPH136 Treatment Patterns and Epidemiological Characteristics in Adult Patients With III-IVB HNSCC From a Reference Center in Mexico

    Dec 1, 2023, 00:00 AM

  • CO86 Comparing Factors Associated With First and Recurrent Psychiatric Hospitalizations in Adult Patients With Major Depressive Disorder Using Cox Proportional Hazard Model and Extensions

    Dec 1, 2023, 00:00 AM

  • EPH232 The Disease Burden and Healthcare Resource Utilization of Gram-Negative Multi-Drug Resistant Bacteria

    Dec 1, 2023, 00:00 AM

  • CO168 A Propensity Score-Based Comparison of Tepotinib Versus Immunotherapy with/without Chemotherapy, Using Real-World Data in Previously Untreated Met Exon 14 (METEX14) Skipping Non-Small Cell Lung Cancer (NSCLC)

    Dec 1, 2023, 00:00 AM

  • EPH105 Effects of Abortion Debate on Fertility Intentions of Women of Childbearing Age

    Dec 1, 2023, 00:00 AM

  • HPR212 The Use of Managed Entry Agreements (MEAs) for Accessing Innovative Health Technologies

    Dec 1, 2023, 00:00 AM

  • PCR207 A Vignette Study to Derive Health-Related Quality of Life Weights for Patients With Steroid Refractory Chronic Graft-Versus-Host Disease Receiving Third Line Therapy in the United Kingdom

    Dec 1, 2023, 00:00 AM

  • MSR53 Flexsurv Methods to Estimate Cure: An Exploration of Methods for Modelling Cure

    Dec 1, 2023, 00:00 AM

  • EPH163 Dental Preventive Examinations and Caries Prevalence in Children Aged 8-14 Years

    Dec 1, 2023, 00:00 AM

  • EE516 Cost-Utility Analysis (CUA) in Chronic Lymphocytic Leukemia (CLL): Is COVID-19’s Impact on National Life Tables Important to Consider?

    Dec 1, 2023, 00:00 AM

  • MT26 Implications of the Implementation of the Joint Committee Assessment on Launch Planning for Medical Technologies in Europe

    Dec 1, 2023, 00:00 AM

  • PCR272 Qualitative Research to Explore Womens Experience of Vasomotor Symptoms and Evaluate the Suitability of Patient-Reported Outcomes

    Dec 1, 2023, 00:00 AM

  • SA25 Caregiver Burden in Growth Hormone Deficiency: A Targeted Review

    Dec 1, 2023, 00:00 AM

  • HTA186 Accelerating Access to Medical Technologies: An Overview of the NICE Early Value Assessment Pilot Project in the UK

    Dec 1, 2023, 00:00 AM

  • P31 Evidence Supporting Regulatory Withdrawals and Quantifying Their Impact on Public Health

    Dec 1, 2023, 00:00 AM

  • P23 Evolving Use of Artificial Intelligence and Machine Learning in Systematic Literature Reviews (SLRs)

    Dec 1, 2023, 00:00 AM

  • PT26 How Aware Are Biotech and Pharmaceutical Companies of the Implementation of the New EU HTA?

    Dec 1, 2023, 00:00 AM

  • CO132 A Real-World Evidence Analysis of the Impact of Patient-Physician Sex Concordance on Cancer Treatment Practices and Outcomes

    Dec 1, 2023, 00:00 AM

  • EPH45 Exploring the Pandemic's Impact: An Examination of Adolescent and Adult Vaccination Rates in Different Countries During COVID-19

    Dec 1, 2023, 00:00 AM

  • HTA198 Comparisons of Economic Evaluation Guidelines Between Japan and Six Countries (England, France, Germany, Sweden, Canada and Australia)

    Dec 1, 2023, 00:00 AM

  • RWD100 Comparison of Real-World Safety and Effectiveness of Mepolizumab and Benralizumab in the Management of Severe Asthma: A Systematic Review

    Dec 1, 2023, 00:00 AM

  • How Do Patients With Type 2 Diabetes Mellitus Value the Importance of Outcomes? An Overview of Reviews

    Dec 1, 2023, 00:00 AM

  • HPR115 Patient Access Network: Multi-Stakeholder Shared Policy Strategies for Medical Device Access

    Dec 1, 2023, 00:00 AM

  • MT51 Does Current Reimbursement Drive the Adoption of Computer-Aided Applications to Increase the Adenoma Detection in Colonoscopies – a Provider-Based Impact Model for Germany, France, and Italy

    Dec 1, 2023, 00:00 AM

  • HTA357 Cost-Comparisons, an Easier Route to NICE Recommendations?

    Dec 1, 2023, 00:00 AM

  • MSR111 Causal Inference and Statistical Considerations for Indirectly Comparing Time-to-Event Endpoints for Treatments with Different Starting Points for Outcome Assessment in Resectable NSCLC

    Dec 1, 2023, 00:00 AM

  • EE308 Cost-Utility Analysis of Universal Neonatal Screening for Critical Congenital Heart Disease Based on Pulse Oximetry in Spain

    Dec 1, 2023, 00:00 AM

  • EE76 End-of-Life Cost and Characteristics of Acute Myeloid Leukemia Decedents: A National Study From 2011-2020

    Dec 1, 2023, 00:00 AM

  • HTA345 Amplifying the Patient Voi Characterising the Impact of Patient and Clinician Engagement (PACE) Meetings on SMC Decision Making

    Dec 1, 2023, 00:00 AM

  • HTA351 A Targeted Review Exploring How English and German Health Technology Assessment Agencies Differ in Their Appraisal of Digital Health Apps

    Dec 1, 2023, 00:00 AM

  • EE218 Budget Impact and Cost Minimization Analysis of Phesgo ® (Trastuzumab + Pertuzumab SC) for the Treatment of HER2+ Breast Cancer in the Chilean Public Health System

    Dec 1, 2023, 00:00 AM

  • HTA118 Estimands in Health Technology Assessments: Methodological Considerations and Recommendations

    Dec 1, 2023, 00:00 AM

  • PCR181 Health-Related Quality-of-Life of Patients Treated with Repotrectinib for Neurotrophic Tyrosine Receptor Kinase (NTRK)-Positive Advanced Solid Tumors: Results from TRIDENT-1

    Dec 1, 2023, 00:00 AM

  • EE411 Cost-per-Responder Analysis of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis

    Dec 1, 2023, 00:00 AM

  • EPH258 Treatment Pattern of Pemphigus Vulgaris in UK : A Retrospective Cohort Study Using Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES)

    Dec 1, 2023, 00:00 AM

  • EE294 Public Health Impact and Cost-Effectiveness of Recombinant Zoster Vaccination Among 50 Years Old or Older in Austria

    Dec 1, 2023, 00:00 AM

  • PCR7 People Living With HIV’s Lived Experiences of Long-Acting Injectable Antiretroviral Treatment Administrations in France Show the Central Role of Hospital Nurses in Care: A Qualitative Study (PANTER)

    Dec 1, 2023, 00:00 AM

  • EE681 Economic Impact of Fixed-Treatment Duration for Chronic Lymphocytic Leukemia: Budget-Impact Analysis of Venetoclax Plus Obinutuzumab for First Line Treatment of Unfit Patients in France

    Dec 1, 2023, 00:00 AM

  • HTA299 A Review of NICE Technology Appraisals of Oncology Treatments in the Past 2 Years – Model Approaches, End of Life Status, and Recommendation Decisions

    Dec 1, 2023, 00:00 AM

  • EE267 Cost-Effectiveness of a Web-Based Interactive Therapeutic Education Platform: Evidence From a Randomized Clinical Trial for Patients With End-Stage Renal Disease

    Dec 1, 2023, 00:00 AM

  • EPH78 A Review of Patient-Reported Outcomes and External Control Arms in Regulatory Submissions of Novel Oncology Drugs

    Dec 1, 2023, 00:00 AM

  • HPR28 Health Technology Assessment of New Drugs in Spain: Understanding the Evaluators’ Evidence Needs

    Dec 1, 2023, 00:00 AM

  • EPH234 Shedding Light into the Dark of Unknown Cost-of-Illness and Burden-of-Disease Associated with RSV across Age Groups in Austria

    Dec 1, 2023, 00:00 AM

  • RWD163 The Economic Burden of Cutaneous Malignant Melanoma in Gree Analysis of Real-Word Health Insurance Data

    Dec 1, 2023, 00:00 AM

  • HTA321 Factors Influencing the Shi Costs of Orphan Drugs After Their Renewed Regular Benefit Assessment Due to Exceeding the Sales Threshold in Germany

    Dec 1, 2023, 00:00 AM

  • EE684 Economic Evaluation of Focal Therapy Used in the Treatment of Prostate Cancer: A Systematic Review

    Dec 1, 2023, 00:00 AM

  • EE609 Economic Evaluation and Return-on-Investment (ROI) of Fostering Physical Activity Policies (Simulation With Two Different Tools)

    Dec 1, 2023, 00:00 AM

  • EE621 Cost-Effectiveness Analysis of iGlarLixi Compared With Basal Bolus Insulin Regimen in Triple Metabolic Goal in Type 2 Diabetes Mellitus in Latin America

    Dec 1, 2023, 00:00 AM

  • MSR20 Estimating Undetected Medication Errors at Care Transitions: A Framework to Support Decision-Making

    Dec 1, 2023, 00:00 AM

  • EE36 Economic Burden of Adults Hospitalized with Respiratory Syncytial Virus Infection in Spain, 2016–2019

    Dec 1, 2023, 00:00 AM

  • RWD93 Quantifying Trends in Price Setting for Traditional and Innovative Advanced Rare Disease Therapies

    Dec 1, 2023, 00:00 AM

  • EE297 Healthcare Resources Utilization Among Sectors in Saudi Arabia

    Dec 1, 2023, 00:00 AM

  • PCR36 Building a COA Strategy in Allergic Fungal Rhinosinusitis: Patient Experiences and Clinical Outcome Assessments from the Literature

    Dec 1, 2023, 00:00 AM

  • HPR52 Working Market for Patients Living With Advanced Breast Cancer in Portugal: Call for Action

    Dec 1, 2023, 00:00 AM

  • The Impact of Cancer Screening Programs on Population Health Outcomes

    Dec 1, 2023, 00:00 AM

  • HTA7 Exploring the Predictive Accuracy of Treatment Waning Methods: An Analysis of Pembrolizumab across Six Oncology Indications

    Dec 1, 2023, 00:00 AM

  • EPH215 Informal Caregiving and Illicit Drug Use in England and Wales

    Dec 1, 2023, 00:00 AM

  • RWD170 Investigating the Association between Pain Burden and Multimorbidity Among United States Adults with Pain

    Dec 1, 2023, 00:00 AM

  • Methodological Statistical Research

    Dec 1, 2023, 00:00 AM
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6 (current)
  • 7
  • 8
  • 9
  • 10
  • »